There were no 5-year survival differences in primary or metastatic melanomas when stratified by site of PDCD4 subcellular expression (log-rank test, p = 0.47 in primary and p = 0.39 in metastatic melanomas), Figure S2c,d. Here, PDCD4 is linked to metastatic melanoma.